Sponsor Pipeline

Spur Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07223944 A Gaucher Disease Gene Therapy Trial With FLT201 Gaucher Disease Type 1 Recruiting
Phase 1/2
NCT06545136 Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2) Gaucher Disease, Type 1 Active, Not Recruiting
Get alerts when Spur Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free